Reset all filters
01 4 Amoxicillin Anhydrous; Clavulanic Acid
02 1Abiraterone Acetate
03 2Ambrisentanum
04 1Anastrozole
05 3Benserazide; Levodopa
06 2Calcitriol
07 3Cefuroxime
08 3Cinacalcet
09 2Dapagliflozin
10 1Exemestane
11 2Fingolimod
12 1Hydroxycarbamide
13 3Imatinib
14 7Lenalidomide
15 1Letrozole
16 2Posaconazole
17 6Temozolomide
18 2Teriflunomide
19 2Tofacitinib
Reset all filters
01 9Capsule
02 21Film Coated Tablet
03 7Hard Capsule
04 3Injection/Infusion Solution
05 1Oral Suspension
06 2Powder For Oral Suspension
07 2Soft Capsule
08 3Tablet
Reset all filters
01 10.25mcg
02 10.25mg
03 10.5mcg
04 10.5mg
05 11.5g
06 110.0mg
07 3100mg
08 1100mg;25mg
09 310mg
10 1140mg
11 214mg
12 115.0mg
13 1180mg
14 11mg
15 22.5mg
16 120.0mg
17 1200mg
18 1200mg;50mg
19 120mg
20 125.0mg
21 2250mg
22 1250mg;62.5mg
23 125mg
24 130mg
25 1400mg
26 1400mg;57mg
27 140mg/5ml
28 15.0mg
29 2500mg
30 1500mg;125mg
31 150mg;12.5mg
32 45mg
33 160mg
34 17.5mg
35 1750mg
36 1875mg;125mg
37 190mg
Reset all filters
01 48Switzerland
Reset all filters
01 1Abiraterone Devatis
02 2Ambrisentan Devatis
03 1Anastrozol Devatis
04 2Calcitriol Devatis ?g
05 3Cefuroxime Devatis iv
06 3Cinacalcet Devatis
07 2Co-Amoxicillin Devatis
08 2Co-Amoxicillin Devatis ( )
09 2Dapagliflozin Devatis
10 1Exemestan Devatis
11 2Fingolimod Devatis
12 1Hydroxycarbamide Devatis
13 2Imatinib Devatis
14 1Imatinib Devatis (teilbar)
15 7Lenalidomide Devatis
16 1Letrozol Devatis
17 3Levodopa Benserazide Devatis ( + )
18 1Posaconazol Devatis
19 1Posaconazole Devatis
20 6Temozolomide Devatis
21 1Teriflunomide Devatis
22 1Teriflunomide Devatis QOD
23 2Tofacitinib Devatis
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 500mg
Packaging :
Brand Name : Abiraterone Devatis
Approval Date : 2023-10-04
Application Number : 68981
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Brand Name : Ambrisentan Devatis
Approval Date : 29/10/2020
Application Number : 67799
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 10mg
Packaging :
Brand Name : Ambrisentan Devatis
Approval Date : 29/10/2020
Application Number : 67799
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Amoxicillin Anhydrous; Clavulanic Acid
Dosage Form : Film Coated Tablet
Dosage Strength : 500mg;125mg
Packaging :
Brand Name : Co-Amoxicillin Devatis
Approval Date : 24/07/2019
Application Number : 67327
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Amoxicillin Anhydrous; Clavulanic Acid
Dosage Form : Film Coated Tablet
Dosage Strength : 875mg;125mg
Packaging :
Brand Name : Co-Amoxicillin Devatis
Approval Date : 24/07/2019
Application Number : 67329
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Amoxicillin Anhydrous; Clavulanic Acid
Dosage Form : Powder For Oral Suspension
Dosage Strength : 400mg;57mg
Packaging :
Brand Name : Co-Amoxicillin Devatis ( )
Approval Date : 07/05/2020
Application Number : 67383
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Amoxicillin Anhydrous; Clavulanic Acid
Dosage Form : Powder For Oral Suspension
Dosage Strength : 250mg;62.5mg
Packaging :
Brand Name : Co-Amoxicillin Devatis ( )
Approval Date : 07/05/2020
Application Number : 67384
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Film Coated Tablet
Dosage Strength : 1mg
Packaging :
Brand Name : Anastrozol Devatis
Approval Date : 25/07/2016
Application Number : 65922
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Tablet
Dosage Strength : 50mg;12.5mg
Packaging :
Brand Name : Levodopa Benserazide Devatis...
Approval Date : 01/12/2021
Application Number : 68472
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Tablet
Dosage Strength : 100mg;25mg
Packaging :
Brand Name : Levodopa Benserazide Devatis...
Approval Date : 01/12/2021
Application Number : 68472
Regulatory Info : Allowed
Registration Country : Switzerland